Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Jonas Sundermeyer - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Caroline Kellner - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Benedikt N Beer - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Lisa Besch - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Angela Dettling - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Letizia Fausta Bertoldi - , Cardio Center (Autor:in)
  • Stefan Blankenberg - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Jeroen Dauw - , DRK Kliniken Berlin Köpenick (Autor:in)
  • Zouhir Dindane - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Dennis Eckner - , Paracelsus Medizinische Privatuniversität Nürnberg (Autor:in)
  • Ingo Eitel - , Deutsches Zentrum für Herz-Kreislaufforschung (DZHK) (Autor:in)
  • Tobias Graf - , Deutsches Zentrum für Herz-Kreislaufforschung (DZHK) (Autor:in)
  • Patrick Horn - , Universitätsklinikum Düsseldorf (Autor:in)
  • Joanna Jozwiak-Nozdrzykowska - , Herzzentrum Leipzig (Autor:in)
  • Paulus Kirchhof - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Stefan Kluge - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Axel Linke - , Medizinische Klinik mit Schwerpunkt Kardiologie (am Herzzentrum) (Autor:in)
  • Ulf Landmesser - , DRK Kliniken Berlin Köpenick (Autor:in)
  • Peter Luedike - , Universitätsklinikum Essen (Autor:in)
  • Enzo Lüsebrink - , University Hospital (Autor:in)
  • Nicolas Majunke - , Herzzentrum Leipzig (Autor:in)
  • Norman Mangner - , Medizinische Klinik mit Schwerpunkt Kardiologie (am Herzzentrum), Technische Universität Dresden (Autor:in)
  • Octavian Maniuc - , Universitätsklinikum Würzburg (Autor:in)
  • Sven Möbius Winkler - , Universitätsklinikum Jena (Autor:in)
  • Peter Nordbeck - , Universitätsklinikum Würzburg (Autor:in)
  • Martin Orban - , University Hospital (Autor:in)
  • Federico Pappalardo - , Dept Cardiothoracic and Vascular Anesthesia and Intensive Care (Autor:in)
  • Matthias Pauschinger - , Paracelsus Medizinische Privatuniversität Nürnberg (Autor:in)
  • Michal Pazdernik - , DRK Kliniken Berlin Köpenick (Autor:in)
  • Alastair Proudfoot - , Barts Health NHS Trust (Autor:in)
  • Matthew Kelham - , Barts Health NHS Trust (Autor:in)
  • Tienush Rassaf - , Universitätsklinikum Essen (Autor:in)
  • Clemens Scherer - , University Hospital (Autor:in)
  • Paul Christian Schulze - , Universitätsklinikum Jena (Autor:in)
  • Robert H G Schwinger - , Medizinische Klinik II/Rheumatologie (Autor:in)
  • Carsten Skurk - , DRK Kliniken Berlin Köpenick (Autor:in)
  • Marek Sramko - , DRK Kliniken Berlin Köpenick (Autor:in)
  • Guido Tavazzi - , IRCCS Fondazione Don Carlo Gnocchi - Milano (Autor:in)
  • Holger Thiele - , Herzzentrum Leipzig (Autor:in)
  • Luca Villanova - , Unità Di Cure Intensive Cardiologiche and De Gasperis Cardio-Center (Autor:in)
  • Nuccia Morici - , IRCCS Fondazione Don Carlo Gnocchi - Milano (Autor:in)
  • Ralf Westenfeld - , Universitätsklinikum Düsseldorf (Autor:in)
  • Ephraim B Winzer - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Dirk Westermann - , Universitätsklinikum Freiburg (Autor:in)
  • Benedikt Schrage - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)

Abstract

BACKGROUND: Currently, use of mechanical circulatory support (MCS) in non-ischaemic cardiogenic shock (CS) is predominantly guided by shock-specific markers, and not by markers of cardiac function. We hypothesise that left ventricular ejection fraction (LVEF) can identify patients with a higher likelihood to benefit from MCS and thus help to optimise their expected benefit.

METHODS: Patients with non-ischaemic CS and available data on LVEF from 16 tertiary-care centres in five countries were analysed. Cox regression models were fitted to evaluate the association between LVEF and mortality, as well as the interaction between LVEF, MCS use and mortality.

RESULTS: N = 807 patients were analysed: mean age 63 [interquartile range (IQR) 51.5-72.0] years, 601 (74.5%) male, lactate 4.9 (IQR 2.6-8.5) mmol/l, LVEF 20 (IQR 15-30) %. Lower LVEF was more frequent amongst patients with more severe CS, and MCS was more likely used in patients with lower LVEF. There was no association between LVEF and 30-day mortality risk in the overall study cohort. However, there was a significant interaction between MCS use and LVEF, indicating a lower 30-day mortality risk with MCS use in patients with LVEF ≤ 20% (hazard ratio 0.72, 95% confidence interval 0.51-1.02 for LVEF ≤ 20% vs. hazard ratio 1.31, 95% confidence interval 0.85-2.01 for LVEF > 20%, interaction-p = 0.017).

CONCLUSION: This retrospective study may indicate a lower mortality risk with MCS use only in patients with severely reduced LVEF. This may propose the inclusion of LVEF as an adjunctive parameter for MCS decision-making in non-ischaemic CS, aiming to optimise the benefit-risk ratio. Impact of left ventricular ejection fraction on mortality and use of mechanical circulatory support in non-ischaemic cardiogenic shock. Hazard ratio for 30-day mortality across the LVEF continuum, adjusted for age, sex, SCAI shock stage, worst value of lactate and pH within 6 h, prior resuscitation and mechanical ventilation during the index shock event. LVEF: Left ventricular ejection fraction; MCS: Mechanical circulatory support; HR: Hazard ratio; CI: Confidence interval.

Details

OriginalspracheEnglisch
FachzeitschriftClinical Research in Cardiology
PublikationsstatusElektronische Veröffentlichung vor Drucklegung - 20 Nov. 2023
Peer-Review-StatusJa

Externe IDs

Scopus 85177055570

Schlagworte